GTB-360
Near Add Your Location
Accepting patients
GTB-3650 Tri-Specific Killer Engager (TriKE®)
HM2023-05: GTB-3650 (Anti-CD16/IL-15/Anti-CD33) Tri-Specific Killer Engager (TriKE®) for the Treatment of High Risk Myelodysplastic Syndromes (MDS) and Refractory/Relapsed Acute Myeloid Leukemia (AML)
- CD16
- CD33
- Interleukin 15 (IL-15)
- Phase 1
Showing 1-1 of 1